Latest profit margin for Mabion S.A.: -321.43% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for MAB.WA is -321.43% as of June 2026. That compares with -576.7% in the prior-year period — up 44.3% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Mabion S.A.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, MAB.WA's profit margin moved from -576.7% to -321.43% — a 44.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mabion S.A.'s valuation or profitability profile.
Against Healthcare companies, MAB.WA currently prints -321.43% for profit margin, while the sector average sits near 10.58%. That is roughly 3138.0% below the sector mean. Large gaps often invite a closer look at Mabion S.A.'s growth, margins, and balance sheet.
Profit Margin shows how effectively Mabion S.A. converts resources into returns. At -321.43%, MAB.WA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -576.7% in the prior-year period — up 44.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MAB.WA's profit margin (-321.43%), review year-over-year change from -576.7%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.